<DOC>
	<DOCNO>NCT02854124</DOCNO>
	<brief_summary>The objective project evaluate presence melanoma quiescent initiate clonal cell peritumoral healthy tissue display molecular signature tumor/metastasis correlate presence prognostic value .</brief_summary>
	<brief_title>Tracing Dissemination Melanoma Cells Healthy Tissues</brief_title>
	<detailed_description>In western world , melanoma incidence constantly rise last 50 year , currently report frequent tumor 20 - 29 year old woman . BRAF , NRAS c-kit gene play important role cell proliferation mutate high frequency melanoma . Despite recent therapeutical breakthrough obtain use new drug , metastatic melanoma remain still life threaten disease . One main question melanoma concern initial step lead metastatic spread , good understand key step prevention identification new molecular mechanism implemental improvement therapeutical arsenal . The propose work aim study hypothesis early spread human melanoma use recently develop powerful technique e-ice cold PCR , well classical immunohistochemistry . To , investigator take advantage fact treatment melanoma relies secondary excision normal peritumoral skin sentinel lymph node . This peritumoral tissue large ( measure 2 6 cm diameter ) , contain lymphatics hypodermis , tissue consider host metastatic route melanocyte remain partially available analysis . All patient stage Ib II melanoma follow parisian cohort Melan-cohort , Cochin Hospital Gustave Roussy Institute include 2005 2009 found . A PCR analysis do DNA extract paraffin embed section primary tumor . Patients display mutation BRAF ( BRAFV600E , BRAFV600K ) , NRAS ( codon 61 ) c-kit gene select . The archival paraffin embed tissue healthy perilesional skin well healthy sentinel lymph node obtain . Pyrosequencing e-ice cold PCR target mutation gene usual position do DNA extract specimen . Immunofluorescence anti-BRAFV600E anti tumoral/initiating/stem cell do tissue . These simple technique test -using sensitive molecular biology tool- whether human melanoma , early dissemination melanoma cell histopathological healthy sentinel lymph node peritumoral skin . The presence clonal cell healthy tissue correlate survival patient 5 year allow development new therapeutic follow-up strategy .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Men woman age &gt; 18 year old . Primary melanomas stage Ib II . Melanomas mutate BRAF , NRAS , ckit . Cutaneous melanoma . Metastatic melanoma stage III IV . Melanomas invasion peritumoral skin tissue . Congenital acquire immunosuppression . Antitumoral , immunosuppressive treatment diseases follow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>Dissemination</keyword>
	<keyword>Initiating stem cell</keyword>
</DOC>